Rutgers University Awarded $14.3M for NIDA Genetic Studies Research and Development

Contract Overview

Contract Amount: $14,364,821 ($14.4M)

Contractor: Rutgers, the State University

Awarding Agency: Department of Health and Human Services

Start Date: 2004-05-01

End Date: 2009-04-30

Contract Duration: 1,825 days

Daily Burn Rate: $7.9K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 3

Pricing Type: FIRM FIXED PRICE

Sector: R&D

Official Description: NIDA CENTER FOR GENETIC STUDIES

Place of Performance

Location: NEW BRUNSWICK, MIDDLESEX County, NEW JERSEY, 08901

State: New Jersey Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $14.4 million to RUTGERS, THE STATE UNIVERSITY for work described as: NIDA CENTER FOR GENETIC STUDIES Key points: 1. The contract supports critical research in genetic studies, a key area for the National Institutes of Health. 2. Rutgers University, a well-established research institution, is the sole awardee. 3. The contract duration is 5 years, indicating a significant, long-term research effort. 4. The award falls under the Research and Development in Physical, Engineering, and Life Sciences NAICS code.

Value Assessment

Rating: good

The contract value of $14.3M over 5 years appears reasonable for a large-scale research project. Benchmarking against similar NIH grants for genetic studies would provide further context.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, suggesting a competitive bidding process. This method typically leads to better price discovery and value for the government.

Taxpayer Impact: The competitive award process aims to ensure taxpayer funds are used efficiently for valuable scientific research.

Public Impact

Advancement of genetic research critical for understanding diseases. Potential for breakthroughs in medical treatments and public health strategies. Supports a major research university and its scientific endeavors. Long-term investment in scientific knowledge and innovation.

Waste & Efficiency Indicators

Waste Risk Score: 78 / 10

Positive Signals

Full and open competition
Established research institution awardee
Clear research objective

Sector Analysis

This contract falls within the R&D sector, specifically focusing on life sciences. Federal spending in this area is crucial for scientific advancement and public health initiatives, with significant annual investments by agencies like NIH.

Small Business Impact

The awardee is a large university, not a small business. There is no indication of subcontracting opportunities for small businesses within the provided data.

Oversight & Accountability

The contract is managed by the National Institutes of Health (NIH), a component of HHS, which has established oversight mechanisms for research grants and contracts to ensure accountability and proper use of funds.

Related Government Programs

Research and Development in the Physical, Engineering, and Life Sciences
Department of Health and Human Services Contracting
National Institutes of Health Programs

Risk Flags

Research inherent risks
Potential for long-term research delays

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $14.4 million to RUTGERS, THE STATE UNIVERSITY. NIDA CENTER FOR GENETIC STUDIES

Who is the contractor on this award?

The obligated recipient is RUTGERS, THE STATE UNIVERSITY.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $14.4 million.

What is the period of performance?

Start: 2004-05-01. End: 2009-04-30.

What specific genetic studies are being funded, and what are the expected outcomes?

The contract supports research at the NIDA Center for Genetic Studies. While specific study details are not provided, the general aim is to advance understanding of genetic factors related to substance use and addiction. Expected outcomes likely include identification of genetic markers, understanding of biological pathways, and potential targets for therapeutic interventions.

Are there any identified risks associated with the research or the awardee's ability to perform?

The primary risks are inherent to scientific research, such as the possibility of inconclusive results or unexpected challenges in data analysis. However, awarding to Rutgers, a reputable institution with a track record in research, mitigates performance risk. The fixed-price contract structure also shifts some financial risk to the contractor.

How does this funding contribute to NIDA's overall research priorities and mission effectiveness?

This funding directly supports NIDA's mission to advance the science of addiction. By investing in genetic research, NIDA aims to uncover the biological underpinnings of addiction, leading to more effective prevention and treatment strategies. This contract is a key component of NIDA's broader portfolio focused on understanding and combating substance use disorders.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences

Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Offers Received: 3

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: ASB III, 3 RUTGERS PLAZA, NEW BRUNSWICK, NJ, 06

Business Categories: Category Business, Educational Institution, Higher Education, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $14,364,821

Exercised Options: $14,364,821

Current Obligation: $14,364,821

Timeline